Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte. [electronic resource]
- Joint bone spine Jan 2020
- 49-55 p. digital
Publication Type: Journal Article
1778-7254
10.1016/j.jbspin.2019.07.011 doi
Adalimumab--therapeutic use Antirheumatic Agents--adverse effects Arthritis, Juvenile--drug therapy Biological Products--adverse effects Child Etanercept--therapeutic use Humans Infections--epidemiology Retrospective Studies